• Home
  • Pharmaceuticals and Healthcare
Anthrax Vaccines Market - Global Outlook and Forecast 2021-2027

Anthrax Vaccines Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ759844 | No. of Pages: 107 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Jun-2021 
The Anthrax Vaccines market report provides the overall market analysis of the industry. This market report presents the current snapshot of the Anthrax Vaccines market to understand the market's key features. The content of the report highlights the important market criteria that help to develop the market further. The report provides the value and the volume of the Anthrax Vaccines at global, regional, and company levels. The historical market value for the year 2021 along with the market value for the upcoming year 2027 has been presented in the market report. Along with that, the report also provides information on subjects such as Export, import, production, and production capacity of the Anthrax Vaccines market.This report contains market size and forecasts of Anthrax Vaccines in global, including the following market information:
Global Anthrax Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Anthrax Vaccines Market Sales, 2016-2021, 2022-2027, (M Doses)
Global top five Anthrax Vaccines companies in 2020 (%)
The global Anthrax Vaccines market was valued at 653.4 million in 2020 and is projected to reach US$ 865.2 million by 2027, at a CAGR of 7.3% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anthrax Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anthrax Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, By Type, 2020 (%)
Live Vaccines
Cell free PA Vaccines

Global Anthrax Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, By Application, 2020 (%)
Human Use
Animal Use

Global Anthrax Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Anthrax Vaccines Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anthrax Vaccines revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Anthrax Vaccines revenues share in global market, 2020 (%)
Key companies Anthrax Vaccines sales in global market, 2016-2021 (Estimated), (M Doses)
Key companies Anthrax Vaccines sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
1 Introduction to Research & Analysis Reports
    1.1 Anthrax Vaccines Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Anthrax Vaccines Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Anthrax Vaccines Overall Market Size
    2.1 Global Anthrax Vaccines Market Size: 2021 VS 2027
    2.2 Global Anthrax Vaccines Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Anthrax Vaccines Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Anthrax Vaccines Players in Global Market
    3.2 Top Global Anthrax Vaccines Companies Ranked by Revenue
    3.3 Global Anthrax Vaccines Revenue by Companies
    3.4 Global Anthrax Vaccines Sales by Companies
    3.5 Global Anthrax Vaccines Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Anthrax Vaccines Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Anthrax Vaccines Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Anthrax Vaccines Players in Global Market
        3.8.1 List of Global Tier 1 Anthrax Vaccines Companies
        3.8.2 List of Global Tier 2 and Tier 3 Anthrax Vaccines Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Anthrax Vaccines Market Size Markets, 2021 & 2027
        4.1.2 Live Vaccines
        4.1.3 Cell free PA Vaccines
    4.2 By Type - Global Anthrax Vaccines Revenue & Forecasts
        4.2.1 By Type - Global Anthrax Vaccines Revenue, 2016-2021
        4.2.2 By Type - Global Anthrax Vaccines Revenue, 2022-2027
        4.2.3 By Type - Global Anthrax Vaccines Revenue Market Share, 2016-2027
    4.3 By Type - Global Anthrax Vaccines Sales & Forecasts
        4.3.1 By Type - Global Anthrax Vaccines Sales, 2016-2021
        4.3.2 By Type - Global Anthrax Vaccines Sales, 2022-2027
        4.3.3 By Type - Global Anthrax Vaccines Sales Market Share, 2016-2027
    4.4 By Type - Global Anthrax Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Anthrax Vaccines Market Size, 2021 & 2027
        5.1.2 Human Use
        5.1.3 Animal Use
    5.2 By Application - Global Anthrax Vaccines Revenue & Forecasts
        5.2.1 By Application - Global Anthrax Vaccines Revenue, 2016-2021
        5.2.2 By Application - Global Anthrax Vaccines Revenue, 2022-2027
        5.2.3 By Application - Global Anthrax Vaccines Revenue Market Share, 2016-2027
    5.3 By Application - Global Anthrax Vaccines Sales & Forecasts
        5.3.1 By Application - Global Anthrax Vaccines Sales, 2016-2021
        5.3.2 By Application - Global Anthrax Vaccines Sales, 2022-2027
        5.3.3 By Application - Global Anthrax Vaccines Sales Market Share, 2016-2027
    5.4 By Application - Global Anthrax Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Anthrax Vaccines Market Size, 2021 & 2027
    6.2 By Region - Global Anthrax Vaccines Revenue & Forecasts
        6.2.1 By Region - Global Anthrax Vaccines Revenue, 2016-2021
        6.2.2 By Region - Global Anthrax Vaccines Revenue, 2022-2027
        6.2.3 By Region - Global Anthrax Vaccines Revenue Market Share, 2016-2027
    6.3 By Region - Global Anthrax Vaccines Sales & Forecasts
        6.3.1 By Region - Global Anthrax Vaccines Sales, 2016-2021
        6.3.2 By Region - Global Anthrax Vaccines Sales, 2022-2027
        6.3.3 By Region - Global Anthrax Vaccines Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Anthrax Vaccines Revenue, 2016-2027
        6.4.2 By Country - North America Anthrax Vaccines Sales, 2016-2027
        6.4.3 US Anthrax Vaccines Market Size, 2016-2027
        6.4.4 Canada Anthrax Vaccines Market Size, 2016-2027
        6.4.5 Mexico Anthrax Vaccines Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Anthrax Vaccines Revenue, 2016-2027
        6.5.2 By Country - Europe Anthrax Vaccines Sales, 2016-2027
        6.5.3 Germany Anthrax Vaccines Market Size, 2016-2027
        6.5.4 France Anthrax Vaccines Market Size, 2016-2027
        6.5.5 U.K. Anthrax Vaccines Market Size, 2016-2027
        6.5.6 Italy Anthrax Vaccines Market Size, 2016-2027
        6.5.7 Russia Anthrax Vaccines Market Size, 2016-2027
        6.5.8 Nordic Countries Anthrax Vaccines Market Size, 2016-2027
        6.5.9 Benelux Anthrax Vaccines Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Anthrax Vaccines Revenue, 2016-2027
        6.6.2 By Region - Asia Anthrax Vaccines Sales, 2016-2027
        6.6.3 China Anthrax Vaccines Market Size, 2016-2027
        6.6.4 Japan Anthrax Vaccines Market Size, 2016-2027
        6.6.5 South Korea Anthrax Vaccines Market Size, 2016-2027
        6.6.6 Southeast Asia Anthrax Vaccines Market Size, 2016-2027
        6.6.7 India Anthrax Vaccines Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Anthrax Vaccines Revenue, 2016-2027
        6.7.2 By Country - South America Anthrax Vaccines Sales, 2016-2027
        6.7.3 Brazil Anthrax Vaccines Market Size, 2016-2027
        6.7.4 Argentina Anthrax Vaccines Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Anthrax Vaccines Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Anthrax Vaccines Sales, 2016-2027
        6.8.3 Turkey Anthrax Vaccines Market Size, 2016-2027
        6.8.4 Israel Anthrax Vaccines Market Size, 2016-2027
        6.8.5 Saudi Arabia Anthrax Vaccines Market Size, 2016-2027
        6.8.6 UAE Anthrax Vaccines Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Emergent BioSolutions
        7.1.1 Emergent BioSolutions Corporate Summary
        7.1.2 Emergent BioSolutions Business Overview
        7.1.3 Emergent BioSolutions Anthrax Vaccines Major Product Offerings
        7.1.4 Emergent BioSolutions Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.1.5 Emergent BioSolutions Key News
    7.2 Merial
        7.2.1 Merial Corporate Summary
        7.2.2 Merial Business Overview
        7.2.3 Merial Anthrax Vaccines Major Product Offerings
        7.2.4 Merial Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.2.5 Merial Key News
    7.3 Merck
        7.3.1 Merck Corporate Summary
        7.3.2 Merck Business Overview
        7.3.3 Merck Anthrax Vaccines Major Product Offerings
        7.3.4 Merck Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.3.5 Merck Key News
    7.4 Zoetis
        7.4.1 Zoetis Corporate Summary
        7.4.2 Zoetis Business Overview
        7.4.3 Zoetis Anthrax Vaccines Major Product Offerings
        7.4.4 Zoetis Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.4.5 Zoetis Key News
    7.5 Bayer Sanidad Animal
        7.5.1 Bayer Sanidad Animal Corporate Summary
        7.5.2 Bayer Sanidad Animal Business Overview
        7.5.3 Bayer Sanidad Animal Anthrax Vaccines Major Product Offerings
        7.5.4 Bayer Sanidad Animal Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.5.5 Bayer Sanidad Animal Key News
    7.6 Colorado Serum
        7.6.1 Colorado Serum Corporate Summary
        7.6.2 Colorado Serum Business Overview
        7.6.3 Colorado Serum Anthrax Vaccines Major Product Offerings
        7.6.4 Colorado Serum Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.6.5 Colorado Serum Key News
    7.7 PharmAthene
        7.7.1 PharmAthene Corporate Summary
        7.7.2 PharmAthene Business Overview
        7.7.3 PharmAthene Anthrax Vaccines Major Product Offerings
        7.4.4 PharmAthene Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.7.5 PharmAthene Key News
    7.8 Tiankang
        7.8.1 Tiankang Corporate Summary
        7.8.2 Tiankang Business Overview
        7.8.3 Tiankang Anthrax Vaccines Major Product Offerings
        7.8.4 Tiankang Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.8.5 Tiankang Key News
    7.9 Biogénesis-Bago
        7.9.1 Biogénesis-Bago Corporate Summary
        7.9.2 Biogénesis-Bago Business Overview
        7.9.3 Biogénesis-Bago Anthrax Vaccines Major Product Offerings
        7.9.4 Biogénesis-Bago Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.9.5 Biogénesis-Bago Key News
    7.10 CAVAC
        7.10.1 CAVAC Corporate Summary
        7.10.2 CAVAC Business Overview
        7.10.3 CAVAC Anthrax Vaccines Major Product Offerings
        7.10.4 CAVAC Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.10.5 CAVAC Key News
    7.11 Rosenbusch
        7.11.1 Rosenbusch Corporate Summary
        7.11.2 Rosenbusch Anthrax Vaccines Business Overview
        7.11.3 Rosenbusch Anthrax Vaccines Major Product Offerings
        7.11.4 Rosenbusch Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.11.5 Rosenbusch Key News
    7.12 Agrovet
        7.12.1 Agrovet Corporate Summary
        7.12.2 Agrovet Anthrax Vaccines Business Overview
        7.12.3 Agrovet Anthrax Vaccines Major Product Offerings
        7.12.4 Agrovet Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.12.5 Agrovet Key News
    7.13 Vecol
        7.13.1 Vecol Corporate Summary
        7.13.2 Vecol Anthrax Vaccines Business Overview
        7.13.3 Vecol Anthrax Vaccines Major Product Offerings
        7.13.4 Vecol Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.13.5 Vecol Key News
    7.14 CVCRI
        7.14.1 CVCRI Corporate Summary
        7.14.2 CVCRI Business Overview
        7.14.3 CVCRI Anthrax Vaccines Major Product Offerings
        7.14.4 CVCRI Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.14.5 CVCRI Key News
    7.15 IVPM
        7.15.1 IVPM Corporate Summary
        7.15.2 IVPM Business Overview
        7.15.3 IVPM Anthrax Vaccines Major Product Offerings
        7.15.4 IVPM Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.15.5 IVPM Key News
    7.16 Prondil
        7.16.1 Prondil Corporate Summary
        7.16.2 Prondil Business Overview
        7.16.3 Prondil Anthrax Vaccines Major Product Offerings
        7.16.4 Prondil Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.16.5 Prondil Key News
    7.17 CDV
        7.17.1 CDV Corporate Summary
        7.17.2 CDV Business Overview
        7.17.3 CDV Anthrax Vaccines Major Product Offerings
        7.17.4 CDV Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.17.5 CDV Key News
    7.18 Indian Immunologicals
        7.18.1 Indian Immunologicals Corporate Summary
        7.18.2 Indian Immunologicals Business Overview
        7.18.3 Indian Immunologicals Anthrax Vaccines Major Product Offerings
        7.18.4 Indian Immunologicals Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.18.5 Indian Immunologicals Key News
    7.19 Botswana Vaccine Institute
        7.19.1 Botswana Vaccine Institute Corporate Summary
        7.19.2 Botswana Vaccine Institute Business Overview
        7.19.3 Botswana Vaccine Institute Anthrax Vaccines Major Product Offerings
        7.19.4 Botswana Vaccine Institute Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.19.5 Botswana Vaccine Institute Key News
    7.20 Ceva Santé Animale
        7.20.1 Ceva Santé Animale Corporate Summary
        7.20.2 Ceva Santé Animale Business Overview
        7.20.3 Ceva Santé Animale Anthrax Vaccines Major Product Offerings
        7.20.4 Ceva Santé Animale Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.20.5 Ceva Santé Animale Key News
    7.21 Intervac
        7.21.1 Intervac Corporate Summary
        7.21.2 Intervac Business Overview
        7.21.3 Intervac Anthrax Vaccines Major Product Offerings
        7.21.4 Intervac Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.21.5 Intervac Key News
    7.22 JOVAC
        7.22.1 JOVAC Corporate Summary
        7.22.2 JOVAC Business Overview
        7.22.3 JOVAC Anthrax Vaccines Major Product Offerings
        7.22.4 JOVAC Anthrax Vaccines Sales and Revenue in Global (2016-2021)
        7.22.5 JOVAC Key News
8 Global Anthrax Vaccines Production Capacity, Analysis
    8.1 Global Anthrax Vaccines Production Capacity, 2016-2027
    8.2 Anthrax Vaccines Production Capacity of Key Manufacturers in Global Market
    8.3 Global Anthrax Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Anthrax Vaccines Supply Chain Analysis
    10.1 Anthrax Vaccines Industry Value Chain
    10.2 Anthrax Vaccines Upstream Market
    10.3 Anthrax Vaccines Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Anthrax Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com